Inactive Instrument

Other languages Acer Therapeutics Inc.

Equities

ACER

US00444P1084

Other languages

Unlock all the news: Be the first to know and act before the market!

Acer Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 20
Chris Schelling Ceases to Be Chief Executive Officer of Acer Therapeutics Inc	Nov. 20
Acer Therapeutics Inc. Announces Executive Changes	Nov. 20
Zevra Therapeutics Completes Acer Acquisition	Nov. 20
Zevra Therapeutics, Inc. completed the acquisition of Acer Therapeutics Inc. from funds affiliated with TVM Capital Life Science and others.	Nov. 16
Zevra Therapeutics, Inc. completed the acquisition of Acer Therapeutics Inc. from funds affiliated with TVM Capital Life Science and others.	Nov. 16
Top Midday Decliners	23-09-01
Sector Update: Health Care Stocks Lower in Late Afternoon Trading	23-08-31
Sector Update: Health Care	23-08-31
Top Midday Gainers	23-08-31
Zevra Therapeutics to Acquire Acer Therapeutics in Merger Deal	23-08-31
Relief Therapeutics Sells License for Urea Cycle Disorder Drug to Acer Therapeutics	23-08-31
Relief Therapeutics Holding AG Announces New Exclusive Definitive License Agreement for OLPRUVA(TM) (ACER-001) with Acer Therapeutics	23-08-30
Relief Therapeutics conclut un accord de licence avec Acer pour Olpruva	23-08-30
Relief Therapeutics schliesst Lizenz-Abkommen mit Acer für Olpruva	23-08-30
Acer Therapeutics Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2023	23-08-14
Acer Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15
Relief Therapeutics Partner Plans Commercial Launch of Rare Genetic Disease Drug by Mid-June	23-05-02
Relief-Partner Acer mit Fortschritten bei Vermarktung von Olpruva	23-05-01
Acer Therapeutics Inc. Provides an Update Indicating That the Commercial Launch Activities for OLPRUVA	23-05-01

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Acer Therapeutics Inc.

Equities

ACER

US00444P1084

Other languages

Filters